Skip to content
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
Menu
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
accuray-logo-20
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Menu
  • Who We Are
    • –
  • Resources
    • –
  • Products
    • –
  • Services
    • –
Search
Close
accuray-logo-20.svg

Technique: SBRT

Single-Fraction PSMA-PET- and Multiparametric MRI-Guided Focal SBRT for Prostate Cancer Local Recurrences

Felix Ehret et al | RSS | 2023

Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old-Updated Results

Christopher Mendez et al | RSS | 2023

Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy

Salvestrini V, Duijm M, Loi M, Nuyttens JJ | Cancers (Basel) | 2022

Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas – A randomized clinical trial

Marcin Miszczyk, Aleksandra Napieralska, Grzegorz Woźniak, Małgorzata Kraszkiewicz, Michał Gola, Michał Kalemba, Grzegorz Głowacki, Bartłomiej Tomasik, Magdalena Kocot-Kępska, Leszek Miszczyk | Radiother Oncol | 2022

2486: Correlation between Obesity and Treatment Failure Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer

D. Conroy, T. Sholklapper, M. K. K. Lawlor, J. M. Cantalino, A. Zwart, M. J. Ayoob, M. Danner, T. Yung, B. T. Collins, S. Lei, A. Rashid, D. Kumar, S. Suy, N. Aghdam, and S. P. Collins | ASTRO | 2022

194: Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial

K. P. Lui, K. Wang, R. C. Chen, B. L. Kane, C. A. Medbery III, K. Underhill Jr, J. R. Gray, A. V. Peddada, and D. B. Fuller | ASTRO | 2022

2026: Efficacy of SBRT in High Volume Metastatic Carcinoma Breast – A Berry Picking Approach in the Era of High Precision Radiotherapy

P.S. Sridhar, P. Anuradha, C. Fareena Taj, S. Suresh, K. Roopesh, R. Ghosh, S. Bj, | ASTRO | 2022

2031: Evaluation of Early Cosmetic Outcome and Toxicity after 5-Fraction Stereotactic Partial Breast Irradiation in Early-Stage Breast Cancer: A Prospective Cohort Study

H.K. Byun, J.S. Chang, H.J. Kim, J. Kim, M.C. Han, S.Y. KIM, R.H. PARK, C.J. Kim, and Y.B. Kim | ASTRO | 2022

3195: Real-World Dose Delivery Accuracy of Prostate SBRT with Tomotherapy Based Target Tracking

L. Goddard, J. Tang, M. K. Garg, W. R. Bodner III, P. Brodin, K. Jeong, and W. A. Tome | ASTRO | 2022

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]

Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers

Jean-Philippe Pignol, Nienke Hoekstra, Derek Wilke, Hannah Dahn, Maureen Nolan, Frank Vicini | Front Oncol | 2021

Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage

Bae SH, Cho KH, Kim YS, Kim SG, Yoo JJ, Lee JM, Lee MH, Lim S, Jung JH, and Lim SH | Transl Cancer Res | 2022

Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma

Chen YX, Zhuang Y, Yang P, Fan J, Zhou J, Hu Y, Zhu WC, Sun J, Zeng ZC. | Technol Cancer Res Treat | 2020

Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage

Bae SH, Cho KH, Kim YS, Kim SG, Yoo JJ, Lee JM, Lee MH, Lim S, Jung JH, and Lim SH | Transl Cancer Res | 2022

High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment

Parisi E, Romeo A, Sarnelli A, Ghigi G, Bellia SR, Neri E, Micheletti S, Dipalma B, Arpa D, Furini G, Burgio MA, Genestreti G, Gurioli C, Sanna S, Bovolato P, Rea F, Storme G, Scarpi E, Arienti C, Tesei A, Polico R | Cancer Radiother | 2017

Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis

Scotti V, Bruni A, Francolini G, Perna M, Vasilyeva P, Loi M, Simontacchi G, Viggiano D, Lanfranchi B, Gonfiotti A, Topulli J, Olmetto E, Maragna V, Ferrari K, Bonti V, Comin C, Balduzzi S, D’Amico R, Lohr F, Voltolini L, Livi L | Clin Lung Cancer | 2019

A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report

Okada W, Doi H, Tanooka M, Sano K, Nakamura K, Sakai Y, Shibata M, Tanaka M | SAGE Open Med Case Rep | 2021

Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience

Sallabanda M, Garcia R, Lorenzana L, Santaolalla I, Abarca J, Sallabanda K | Cureus | 2021

Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection

Baumann BC, Nagda SN, Kolker JD, Levin WP, Weber KL, Berman AT, Staddon A, Hartner L, Hahn SM, Glatstein E, Simone CB | J Surg Oncol. | 2016

Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer

Kunos CA, Sherertz TM, Mislmani M, Ellis RJ, Lo SS, Waggoner SE, Zanotti KM, Herrmann K, Debernardo RL | Front Oncol | 2015

← older
Facebook-f Linkedin Twitter Youtube
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
  • CyberKnife®
  • Radixact®
  • TomoTherapy®
  • Accuray Precision® Treatment Planning
  • iDMS® Data Management
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
  • Careers
  • Services
  • Patients
  • Investors
  • Contact Us
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks
  • Conflict Minerals Policy Statement
  • Privacy Policy
  • Terms of Use
  • EthicsPoint Hotline
  • Cookie Use Notice
  • India eWaste Management Program
  • Trademarks

Safety Statement for Radiation Treatment:
Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death. Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient’s general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.

© 2023 Accuray Incorporated, All Rights Reserved. The stylized Accuray logo, CyberKnife, VSI, M6, TomoTherapy, H Series, Tomo, TomoH, TomoHD, TomoHDA, TomoEDGE, TomoHelical, TomoDirect, Hi·Art, PlanTouch, PreciseART, PreciseRTX, Radixact, Accuray Precision, iDMS, Iris, Xchange, RoboCouch, InCise, MultiPlan, Xsight, Synchrony, InTempo, TxView, PlanTouch, QuickPlan, TomoHelical, TomoDirect, TomoEDGE, CTrue, ClearRT, VoLO, Planned Adaptive, TQA, TomoLink, TomoPortal, OIS Connect and AERO are trademarks or registered trademarks of Accuray Incorporated, in the United States and other countries and may not be used or distributed without written authorization from Accuray Incorporated. Use of Accuray Incorporated’s trademarks requires written authorization from Accuray Incorporated.

  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
  • Home
  • AI Real-time Tracking
  • Hypofractionation Trend
  • 20+ Years of Evidence
  • Adaptation in Action
  • CyberKnife® S7™
  • Radixact®
Who we are
  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Events
  • Partners
  • Investors
Resources

  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Treatment Centers

Find a Facility Near You

Products
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratmento
  • Resources
  • Overview
  • Entrega do Tratamento
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®
Services
  • Service Overview
  • Site Planning and Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Technology Upgrades
  • Service Support
  • Customer Resources
  • AERO™ Community
  • Service Requests
  • Contact Us
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
  • Patients
  • Newsroom
  • Investors
  • Accuray Exchange
  • Careers
  • Contact
  • English
  • English

Unmatched service to protect uptime and maximize ROI

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

  • Service Overview
  • Site Planning And Installation
  • Training
  • CyberKnife®
  • Radixact®
  • Alliance Advances
  • Service Support
  • Customer Resources
  • Contact
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Overview
  • Treatment Delivery
  • Resources
  • Accuray Precision® Treatment Planning
  • PreciseART®
  • PreciseRTX®
  • iDMS® Data Management
  • Synchrony®
  • RayStation®
  • RayCare®

Redefining the future of cancer care

Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.

Treatment Centers

Find a Facility Near You
  • 20+ Years of Evidence
  • Blog
  • Innovation
  • Case Studies
  • Patients
  • Product Resources
  • Veterinary Oncology
  • Cybersecurity

Accuray treatment options

The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.

Treatment Centers

Find a Facility Near You

Breast

  • IMRT with TomoHelical™
  • 3DCRT with TomoDirect™

Intracranial

  • SRS with CyberKnife ®

Prostate

  • SBRT with CyberKnife®

Lung

  • SBRT with CyberKnife®

Head and Neck

  • IMRT with TomoHelical™

Veterinary

  • Veterinary Oncology with
    CyberKnife® & TomoTherapy®

About Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.

  • Company
  • Leadership
  • Careers
  • Locations
  • News
  • Media
  • Corporate Citizenship
  • Events
  • Partners
  • Investors